<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>RFK Jr. takes shortcut to make some unapproved peptides available for use — Live Feed</title><link>https://www.live-feeds.com/feed/rfk-jr-takes-shortcut-to-make-some-unapproved-peptides-available-for-use</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/rfk-jr-takes-shortcut-to-make-some-unapproved-peptides-available-for-use/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>RFK Jr. Overrules FDA to Allow Sale of Unapproved Peptides</title><link>https://www.live-feeds.com/feed/rfk-jr-takes-shortcut-to-make-some-unapproved-peptides-available-for-use</link><guid isPermaLink="false">https://www.live-feeds.com/feed/rfk-jr-takes-shortcut-to-make-some-unapproved-peptides-available-for-use#u166440</guid><pubDate>Sat, 31 Oct 2026 15:45:43 +0000</pubDate><description>The Trump administration will allow pharmacies to make and sell popular peptide injections, utilizing a shortcut that grants broad access to unapproved products. Health Secretary RFK Jr. unilaterally authorized availability for the compounds, overriding the Food and Drug Administration. The decision cheered gray-market peptide vendors and compounding pharmacies, while bypassing standard federal drug safety evaluations. Studies show rising use of untested compounds like the Wolverine peptide, often obtained through compounding pharmacies or alternative vendors to manage pain and gastrointestina</description></item>
</channel></rss>